Tsung-Wei Chen

772 total citations
28 papers, 540 citations indexed

About

Tsung-Wei Chen is a scholar working on Oncology, Immunology and Surgery. According to data from OpenAlex, Tsung-Wei Chen has authored 28 papers receiving a total of 540 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 8 papers in Immunology and 7 papers in Surgery. Recurrent topics in Tsung-Wei Chen's work include Cancer Immunotherapy and Biomarkers (12 papers), Colorectal Cancer Treatments and Studies (5 papers) and Colorectal Cancer Surgical Treatments (5 papers). Tsung-Wei Chen is often cited by papers focused on Cancer Immunotherapy and Biomarkers (12 papers), Colorectal Cancer Treatments and Studies (5 papers) and Colorectal Cancer Surgical Treatments (5 papers). Tsung-Wei Chen collaborates with scholars based in Taiwan, South Korea and China. Tsung-Wei Chen's co-authors include Shu‐Fen Chiang, K. S. Clifford Chao, William Tzu‐Liang Chen, Tao‐Wei Ke, Kevin Chih‐Yang Huang, Ying‐Shu You, Chen‐Yu Lin, Chih‐Yang Huang, Ji‐An Liang and Jen‐Wei Chou and has published in prestigious journals such as Gastroenterology, PLoS ONE and Scientific Reports.

In The Last Decade

Tsung-Wei Chen

26 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tsung-Wei Chen Taiwan	13	265	190	178	84	64	28	540
Omar Elaskalani Australia	8	246 0.9×	240 1.3×	198 1.1×	39 0.5×	99 1.5×	11	568
Vichnou Poirier-Colame France	8	212 0.8×	159 0.8×	291 1.6×	28 0.3×	40 0.6×	9	529
Hongze Chen China	14	209 0.8×	319 1.7×	83 0.5×	131 1.6×	214 3.3×	21	594
Ashwat Nagarajan United States	3	335 1.3×	178 0.9×	313 1.8×	20 0.2×	59 0.9×	4	620
Katerina Kachler Germany	13	187 0.7×	232 1.2×	233 1.3×	55 0.7×	83 1.3×	16	612
Liyan Li China	15	72 0.3×	187 1.0×	146 0.8×	35 0.4×	57 0.9×	62	645
Shinichirou Izawa Japan	4	226 0.9×	63 0.3×	276 1.6×	51 0.6×	31 0.5×	4	404
Eva Gückel Germany	10	135 0.5×	305 1.6×	274 1.5×	49 0.6×	53 0.8×	12	559
Oscar W.H. Yeung Hong Kong	8	197 0.7×	205 1.1×	336 1.9×	77 0.9×	124 1.9×	12	635
Gayathri Anandappa United Kingdom	8	392 1.5×	183 1.0×	300 1.7×	38 0.5×	101 1.6×	18	698

Countries citing papers authored by Tsung-Wei Chen

Since Specialization

Citations

This map shows the geographic impact of Tsung-Wei Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tsung-Wei Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tsung-Wei Chen more than expected).

Fields of papers citing papers by Tsung-Wei Chen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tsung-Wei Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tsung-Wei Chen. The network helps show where Tsung-Wei Chen may publish in the future.

Co-authorship network of co-authors of Tsung-Wei Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Tsung-Wei Chen. A scholar is included among the top collaborators of Tsung-Wei Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tsung-Wei Chen. Tsung-Wei Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Huang, Kevin Chih‐Yang, Shu‐Fen Chiang, Shin‐Lei Peng, et al.. (2024). TNFα modulates PANX1 activation to promote ATP release and enhance P2RX7-mediated antitumor immune responses after chemotherapy in colorectal cancer. Cell Death and Disease. 15(1). 24–24. 25 indexed citations

Ke, Tao‐Wei, Shu‐Fen Chiang, Tsung-Wei Chen, et al.. (2024). Prognostic Value of Immune Cells Subsets Within the Tumor Microenvironment in Patients With Rectal Adenocarcinoma. Anticancer Research. 44(2). 787–796. 3 indexed citations

Chen, Chia-Yi, Shu‐Fen Chiang, Tsung-Wei Chen, et al.. (2024). Dual Inhibition of B7-H3 and EGFR Overcomes Acquired Chemoresistance in Colon Adenocarcinoma. Journal of Cancer. 15(6). 1750–1761. 8 indexed citations

Chang, Chia‐Lin, Kevin Chih‐Yang Huang, Tsung-Wei Chen, et al.. (2023). Impact of Pattern Recognition Receptors on the Prognosis of Chemotherapy-treated Rectal Cancer Patients. In Vivo. 37(4). 1552–1561.

Chiang, Shu‐Fen, Chia-Yi Chen, Tsung-Wei Chen, et al.. (2023). Targeting CD73 increases therapeutic response to immunogenic chemotherapy by promoting dendritic cell maturation. Cancer Immunology Immunotherapy. 72(7). 2283–2297. 20 indexed citations

Chou, Jen‐Wei, et al.. (2022). ABO blood type and clinical characteristics of patients with ulcerative colitis: A hospital-based study in central Taiwan. PLoS ONE. 17(2). e0260018–e0260018. 2 indexed citations

Chen, Tsung-Wei, Shu‐Fen Chiang, William Tzu‐Liang Chen, et al.. (2022). Dual inhibition of TGFβ signaling and CSF1/CSF1R reprograms tumor-infiltrating macrophages and improves response to chemotherapy via suppressing PD-L1. Cancer Letters. 543. 215795–215795. 38 indexed citations

Huang, Kevin Chih‐Yang, Shu‐Fen Chiang, Hsin-Yu Chang, et al.. (2022). Engineered sTRAIL-armed MSCs overcome STING deficiency to enhance the therapeutic efficacy of radiotherapy for immune checkpoint blockade. Cell Death and Disease. 13(7). 610–610. 21 indexed citations

Chiang, Shu‐Fen, Kevin Chih‐Yang Huang, William Tzu‐Liang Chen, et al.. (2021). Polymorphism of formyl peptide receptor 1 (FPR1) reduces the therapeutic efficiency and antitumor immunity after neoadjuvant chemoradiotherapy (CCRT) treatment in locally advanced rectal cancer. Cancer Immunology Immunotherapy. 70(10). 2937–2950. 10 indexed citations

10.

Chou, Jen‐Wei, et al.. (2021). Adverse Gastrointestinal Effects with Kayexalate or Kalimate: A Comprehensive Review. Clinical and Experimental Gastroenterology. Volume 14. 1–18. 10 indexed citations

11.

Huang, Kevin Chih‐Yang, Shu‐Fen Chiang, Tao‐Wei Ke, et al.. (2021). DNMT1 constrains IFNβ-mediated anti-tumor immunity and PD-L1 expression to reduce the efficacy of radiotherapy and immunotherapy. OncoImmunology. 10(1). 1989790–1989790. 24 indexed citations

12.

Huang, Kevin Chih‐Yang, Shu‐Fen Chiang, Tsung-Wei Chen, et al.. (2020). Prognostic relevance of programmed cell death 1 ligand 2 (PDCD1LG2/PD-L2) in patients with advanced stage colon carcinoma treated with chemotherapy. Scientific Reports. 10(1). 22330–22330. 16 indexed citations

13.

Chen, Tsung-Wei, et al.. (2020). A rare cause of abdominal pain with bloody stool. The Turkish Journal of Gastroenterology. 31(1). 73–74. 1 indexed citations

14.

Chou, Jen‐Wei, et al.. (2019). Epidemiology and Clinical Outcomes of Inflammatory Bowel Disease: A Hospital-Based Study in Central Taiwan. Gastroenterology Research and Practice. 2019. 1–8. 30 indexed citations

15.

Chen, Tsung-Wei, Kevin Chih‐Yang Huang, Shu‐Fen Chiang, et al.. (2019). Prognostic relevance of programmed cell death-ligand 1 expression and CD8+ TILs in rectal cancer patients before and after neoadjuvant chemoradiotherapy. Journal of Cancer Research and Clinical Oncology. 145(4). 1043–1053. 45 indexed citations

16.

Huang, Kevin Chih‐Yang, Shu‐Fen Chiang, Tao‐Wei Ke, et al.. (2018). Clinical significance of programmed death 1 ligand-1 (CD274/PD-L1) and intra-tumoral CD8+ T-cell infiltration in stage II–III colorectal cancer. Scientific Reports. 8(1). 15658–15658. 52 indexed citations

17.

Chiang, Shu‐Fen, Kevin Chih‐Yang Huang, Tao‐Wei Ke, et al.. (2018). Upregulation of tumor PD-L1 by neoadjuvant chemoradiotherapy (neoCRT) confers improved survival in patients with lymph node metastasis of locally advanced rectal cancers. Cancer Immunology Immunotherapy. 68(2). 283–296. 38 indexed citations

18.

Huang, Chih‐Yang, Shu‐Fen Chiang, William Tzu‐Liang Chen, et al.. (2018). HMGB1 promotes ERK-mediated mitochondrial Drp1 phosphorylation for chemoresistance through RAGE in colorectal cancer. Cell Death and Disease. 9(10). 1004–1004. 129 indexed citations

19.

Ciudad, Pedro, Oscar J. Manrique, Wei‐Ling Chang, et al.. (2017). Recurrent Advanced Lower Extremity Lymphedema Following Initial Successful Vascularized Lymph Node Transfer: A Clinical and Histopathological Analysis. Archives of Plastic Surgery. 44(1). 87–89. 4 indexed citations

20.

Chen, Yang‐Yuan, Tsung-Wei Chen, & Yung‐Fang Chen. (2013). Asymptomatic Multiple Gastric and Duodenal Tumors. Gastroenterology. 145(3). e7–e8. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact